Cardiac Marker Market Research Reveals Strong 12.9% CAGR Outlook Through 2030

The Business Research Company

The Business Research Company’s Cardiac Marker Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, July 30, 2026 /EINPresswire.com/ -- The cardiac marker market has been experiencing significant expansion as advancements in cardiac diagnostics continue to evolve. With cardiovascular diseases remaining a major health concern worldwide, the demand for precise and timely testing solutions is accelerating. Let’s explore the current market size, growth drivers, regional dominance, and trends shaping the future of this critical healthcare segment.

Cardiac Marker Market Size and Projected Growth from 2025 to 2030
The market for cardiac markers has seen rapid growth in recent years. It is projected to increase from $12.38 billion in 2025 to $13.95 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.7%. This upward trajectory during the historical period is largely driven by the rising incidence of cardiovascular diseases, the expansion of hospital laboratory infrastructure, greater utilization of emergency cardiac testing, increased reliance on biomarker-based diagnostics, and advancements in assay sensitivity.

Looking ahead, the cardiac marker market is expected to grow even more swiftly, reaching $22.7 billion by 2030 at a CAGR of 12.9%. Factors fueling this forecasted growth include the rising demand for faster diagnostic turnaround times, broader integration of cardiac diagnostic tools with digital platforms, expansion of point-of-care testing facilities, wider adoption of advanced biomarker panels, and a growing focus on precision cardiology. Key market trends anticipated during this period encompass the increased use of high-specificity marker panels, the uptake of automated immunoassay systems, a surge in demand for rapid cardiac diagnostics, the rise of multiparametric testing strategies, and the enhanced deployment of clinical decision support tools.

Download a free sample of the cardiac marker market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR

Understanding Cardiac Markers and Their Role in Diagnosis
Cardiac markers are specific biological molecules released into the bloodstream when the heart muscle is damaged or stressed. These markers play a vital role in diagnosing and monitoring a range of cardiac conditions such as myocardial infarctions (heart attacks), angina, and heart failure. Their detection provides clinicians with crucial insights into the severity and progression of heart-related illnesses, enabling timely and targeted therapeutic interventions.

Primary Factors Propelling Growth in the Cardiac Marker Market
One of the main drivers behind the expansion of the cardiac marker market is the growing prevalence of cardiovascular diseases globally. These diseases encompass various disorders affecting the heart’s structure and function, leading to significant health complications. Since cardiac markers are essential for diagnosing and tracking these conditions, the demand for related diagnostic tests has surged accordingly.
For example, in January 2024, the American Heart Association, a leading US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. This increase highlights the ongoing and expanding burden of cardiac illnesses, which in turn stimulates demand for improved cardiac marker testing.

View the full cardiac marker market report:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR

Dominant Regions in the Cardiac Marker Market
In 2025, North America held the largest share of the cardiac marker market. The comprehensive market analysis encompasses various key regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Each of these areas presents unique opportunities and challenges, but North America’s established healthcare infrastructure and high adoption rate of advanced diagnostics have positioned it as the market leader.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.